Orthopedic Biomaterials Market Size

Orthopedic Biomaterials Market Future Prospects

The global orthopedic biomaterials market accounts for an estimated revenue of USD 22.3 billion in 2024, which is set to increase to USD 38.8 billion by 2032, advancing at a CAGR of 7.3% during 2025–2032. The increasing demand for next-generation orthopedic biomaterials that can be custom-made to fit the needs of specific operations has fueled the worldwide market expansion. In this regard, the rising number of orthopedic operations, such as joint arthroplasty, viscosupplementation, and joint reconstruction, is essentially contributing to the market's expansion.

Researches in the field of biomaterial technology, including research on biocompatibility, biodegradability, and bioactivity, have significantly improved surgical outcomes and made it possible to produce customized implants for each patient. Advanced technologies, such as 3D printing and computer-aided design, bring a revolution in the manufacturing of orthopedic biomaterials from exact-to-order solutions to boost patient satisfaction.